CTI Biopharma Corp  CTIC
Data as of 07-29-2015 12:00 AM CT
Last PriceDay ChangeVolume
0.07 (3.76%)
Open PriceDay Range52-Wk Range
1.94 - 1.87
Mkt Cap($mil)YieldAvg Volume
 Stock Chart
Price Graph
 Key Stats
Morningstar Style BoxSmall GrowthStock TypeSpeculative Growth
Market Cap $Mil348 Sales $Mil61
 Company Profile
What Does This Company Do?
Cell Therapeutics develops, acquires, and commercializes cancer treatment methods, with an emphasis on reducing the side effects of traditional cancer treatments such as radiation and chemotherapy. The company’s lead products, XYTOTAX and Pixantrone, are both late-stage development drug candidates designed to improve the effectiveness of chemotherapy and tumor-killing drugs. Cell Therapeutics operates in Seattle, Washington and Bresso (Milan), Italy.
Address3101 Western Avenue
 Suite 600
 Seattle, WA, 98121
Phone1 206 282-7100
Direct InvestmentNo
Dividend ReinvestmentNo
All quote data supplied by Morningstar Real-Time Data. Quotes for Nasdaq, NYSE and securities are delayed 20 minutes. © Copyright 2010 Morningstar, Inc.
Show Data Definitions
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2015 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.